DrugPatentWatch Database Preview
Patent: 9,775,844
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Patent: 9,775,844
| Title: | Heterocyclic compounds and uses thereof |
| Abstract: | Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein. |
| Inventor(s): | Kutok; Jeffery L. (Natick, MA), Winkler; David G. (Arlington, MA), Palombella; Vito J. (Needham, MA), Castro; Alfredo C. (Woburn, MA), Evans; Catherine A. (Somerville, MA), Janardanannair; Somarajannair (Woburn, MA), Lescarbeau; Andre (Somerville, MA), Liu; Tao (Wellesley, MA), Tremblay; Martin R. (Melrose, MA) |
| Assignee: | Infinity Pharmaceuticals, Inc. (Cambridge, MA) |
| Application Number: | 14/661,656 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,775,844
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | OPDIVO | nivolumab | INJECTABLE;INJECTION | 125554 | 001 | 2015-11-23 | Start Trial | Infinity Pharmaceuticals, Inc. (Cambridge, MA) | 2034-03-19 | RX | Orphan | search |
| Bristol Myers Squibb | OPDIVO | nivolumab | INJECTABLE;INJECTION | 125527 | 002 | 2015-03-04 | Start Trial | Infinity Pharmaceuticals, Inc. (Cambridge, MA) | 2034-03-19 | RX | search | |
| Bristol Myers Squibb | OPDIVO | nivolumab | INJECTABLE;INJECTION | 125527 | 001 | 2015-03-04 | Start Trial | Infinity Pharmaceuticals, Inc. (Cambridge, MA) | 2034-03-19 | RX | search | |
| Merck Sharp Dohme | KEYTRUDA | pembrolizumab | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER | 125514 | 001 | 2014-09-04 | Start Trial | Infinity Pharmaceuticals, Inc. (Cambridge, MA) | 2034-03-19 | RX | search | |
| Bristol Myers Squibb | YERVOY | ipilimumab | INJECTABLE; INJECTION | 125377 | 001 | 2011-03-25 | Start Trial | Infinity Pharmaceuticals, Inc. (Cambridge, MA) | 2034-03-19 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,775,844
| Country | Patent Number | Publication Date |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2015143012 | Sep 24, 2015 |
| United States of America | 2015290207 | Oct 15, 2015 |
| United States of America | 2018055852 | Mar 01, 2018 |
| Singapore | 10201808053X | Oct 30, 2018 |
| Singapore | 11201607705X | Oct 28, 2016 |
| >Country | >Patent Number | >Publication Date |
